1.	Smoking Cessation Program in the Preadmission Clinic Phase: Phase IV Type: Behavioral study, Prevention Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 07-0585-AE, Protocol# in Pfizer: GA30517W, NCT00937508
2.	Menstrual Cycle Effects on Smoking Cessation and Cue Reactivity Phase: Phase IV Type: Behavioral study, Prevention Status: Active Age: 16 to 45 Sponsor: Other Protocol IDs: P50DA016511, NCT00664755
3.	Combining Varenicline and Bupropion for Smoking Cessation Phase: Phase III Type: Educational/Counseling/Training, Prevention Status: Active Age: 25 to 65 Sponsor: NCI, Other Protocol IDs: 2008-0850, R01DA024709-01A1, NCT00943618
4.	Extended Varenicline Treatment for Smoking Among Cancer Patients Phase: Phase III Type: Behavioral study Status: Active Age: 18 and over Sponsor: Other Protocol IDs: R01CA165001, NCT01756885
5.	Smoking Cessation for American Indians Phase: Phase II, Phase I Type: Behavioral study, Prevention Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: 11862, NCT01106456
6.	Do Treatments for Smoking Cessation Affect Alcohol Drinking? Study 2: Do Varenicline (Chantix) and Bupropion (Zyban) Change Alcohol Drinking? Phase: Phase II Type: Behavioral study, Prevention Status: Active Age: 21 and over Sponsor: Other Protocol IDs: HIC0702002391, R01AA015596-01, NCT00580645
7.	Smoking Cessation Treatment for Head and Neck Cancer Patients Phase: No phase specified Type: Behavioral study, Prevention Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 0903004910, NCT00931021
8.	Varenicline and Motivational Advice for Smokers With Substance Use Disorders Phase: No phase specified Type: Behavioral study Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: 1RO1DA02465201, NIH Appl. ID: 7439661, NIH Award: RDA024652A, NCT00756275
9.	Exercise or Relaxation for Smoking Cessation Phase: No phase specified Type: Behavioral study Status: Active Age: 50 and over Sponsor: NCI, Other Protocol IDs: 09-097-2, 1RO1 DA024872-01A1, NCT00921388
10.	Smoking Cessation Using Motivational Therapy and Varenicline Phase: No phase specified Type: Behavioral study, Prevention Status: Active Age: 18 and over Sponsor: NHLBI Protocol IDs: 2007H0173, R01HL090313, NCT00701896
11.	Smoking Cessation Treatment for Head & Neck Cancer Patients Phase: No phase specified Type: Behavioral study Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2009-0362, NCT01098955
12.	Impact of a Gene Test for Susceptibility to Lung Cancer in Smokers Phase: No phase specified Type: Behavioral study, Prevention Status: Active Age: 20 to 60 Sponsor: Other Protocol IDs: SPCRU1, NCT01176383
13.	Tobacco Dependence in Breast Cancer Patients Scheduled for Mastectomy/Reconstructive Surgery Trial of Varenicline (Chantix) Phase: No phase specified Type: Behavioral study, Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 11-136, NCT01532232
14.	Varenicline or Nicotine Patch in Promoting Smoking Cessation Among Current Smokers Phase: No phase specified Type: Behavioral study, Prevention Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: I 221312, NCI-2012-02755, NCT01771627